Regeneron Seeks FDA's Emergency Use Authorization For COVID-19 Antibody Treatment Given To President Trump

Name: Regeneron Seeks FDA's Emergency Use Authorization For COVID-19 Antibody Treatment Given To President Trump
Uploaded: 2020-10-08T21:52:14+00:00
Duration: P135S
Description: Pres. Donald Trump credits drug maker Regeneron's treatment for relieving his COVID-19 symptoms. But, what is it, and how might you get it? CBS2's Meg Baker

Video Credit: CBS 2 New York - Duration: 02:15s - Published on October 8, 2020

Regeneron Seeks FDA's Emergency Use Authorization For COVID-19 Antibody Treatment Given To President Trump

Pres.

Donald Trump credits drug maker Regeneron's treatment for relieving his COVID-19 symptoms. But, what is it, and how might you get it?

CBS2's Meg Baker reports.

0 shares	Share Tweet Save Post Send

Related videos from verified sources

Regeneron says its COVID-19 drug cut patient visits [Video]

Regeneron says its COVID-19 drug cut patient visits

Regeneron said on Wednesday its coronavirus antibody cocktail - used to treat U.S. President Donald Trump - significantly reduced medical visits in a trial of nearly 800 patients. Gloria Tso reports.

Credit: Reuters - Politics Duration: 01:56Published on October 29, 2020

Preventing COVID-19: UCHealth Asking People Exposed To Virus To Try Regeneron Antibody Treatment [Video]

Preventing COVID-19: UCHealth Asking People Exposed To Virus To Try Regeneron Antibody Treatment

If you live with someone who recently tested positive for COVID-19, UCHealth wants you to try an antibody treatment that could reduce your chance of being infected.

Credit: CBS 4 Denver Duration: 01:43Published on October 27, 2020